☆ 4.6 Article

Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy

ALLERGY (2022)

Related references

Note: Only part of the references are listed.

Article Allergy

Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy

Andrzej Eljaszewicz et al.

Summary: This study found that AIT treatment can induce changes in the composition and heterogeneity of circulating innate immune cells, bringing them to the level observed in healthy individuals. Monitoring of ILCs, monocytes, and DCs during AIT may serve as a novel biomarker strategy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Allergy

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite?induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Pascal Demoly et al.

Summary: The study evaluated the efficacy and safety of a 300 index of reactivity sublingual tablet for allergic rhinitis induced by house dust mites, showing significant improvement in symptoms and good tolerability. This treatment is proven to be effective and safe for patients with moderate to severe allergic rhinitis.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response

Korneliusz Golebski et al.

Summary: IL-10(+) ILC2s play a crucial role in modulating grass-pollen allergy, attenuating Th responses, and maintaining epithelial cell integrity. Patients with grass-pollen allergy have lower levels of IL-10(+) KLRG1(+) ILC2s, but this ability to produce IL-10 is restored after immunotherapy treatment. The mechanisms underlying this involve modifications in retinol metabolic pathway, cytokine-cytokine receptor interaction, and JAK-STAT signaling pathways in the ILCs.

IMMUNITY (2021)

Add to Collection

Article Allergy

Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy

Hanisah Sharif et al.

Summary: This study aimed to evaluate the role of circulating CXCR5(+)PD-1(+) T follicular helper (cT(FH)) and T follicular regulatory (T-FR) cells in grass pollen allergic patients following different immunotherapy treatments. The findings showed dysregulation of cT(FH) cells in the grass pollen allergic group compared to nonatopic healthy controls, as well as induction of T-FR and IL-101 cT(FH) cells following specific immunotherapy. Changes in chromatin landscape were observed in cT(FH) and T-FR cells post-immunotherapy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Review Allergy

The role of allergen-specific IgE, IgG and IgA in allergic disease

Mohamed H. Shamji et al.

Summary: IgE-mediated allergy is a common hypersensitivity disease impacting over 30% of the population. Allergen-specific IgE triggers release of inflammatory mediators, while inducing IgG and IgA antibodies can compete with IgE for allergen binding to prevent allergic responses. Anti-IgE treatment can also prevent IgE from binding to receptors on mast cells and basophils to inhibit allergic reactions.

ALLERGY (2021)

Add to Collection

Article Allergy

Decrease in CD38+ TH2A cell frequencies following immunotherapy with house dust mite tablet correlates with humoral responses

Sonia Luce et al.

Summary: This study confirms the importance of monitoring TH2A cell frequencies in allergic individuals and extends the observation to perennial allergies to HDM. CD38 may help better identify the subset of TH2A cells down-regulated by AIT. The coordinated pathways observed between cellular and humoral responses in immunoreactive individuals highlight the adaptive responses during AIT.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Add to Collection

Article Allergy

Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy

Mohamed H. Shamji et al.

Summary: The study compared allergic responses in nasal and systemic fluids during sublingual immunotherapy (SLIT) and subcutaneous immunotherapy (SCIT) for grass pollen allergy, suggesting key differences in immunological mechanisms between the two treatments.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Allergy

Induction of IgG2 and IgG4 B-cell memory following sublingual immunotherapy for ryegrass pollen allergy

Jorn J. Heeringa et al.

ALLERGY (2020)

Add to Collection

Letter Allergy

Th2A and Th17 cell frequencies and regulatory markers as follow-up biomarker candidates for successful multifood oral immunotherapy

Sonia Luce et al.

ALLERGY (2020)

Add to Collection

Article Allergy

Mechanisms of Subcutaneous and updates Sublingual Aeroallergen Immunotherapy: What Is New?

Zsolt Istvan Komlosi et al.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2020)

Add to Collection

Article Allergy

IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergy

Gabriela Sanchez Acosta et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Review Allergy

Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma

Heimo Breiteneder et al.

ALLERGY (2020)

Add to Collection

Review Allergy

2019 ARIA Care pathways for allergen immunotherapy

Jean Bousquet et al.

ALLERGY (2019)

Add to Collection

Article Allergy

EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma

Ioana Agache et al.

ALLERGY (2019)

Add to Collection

Review Allergy

Perspectives in allergen immunotherapy: 2019 and beyond

Oliver Pfaar et al.

ALLERGY (2019)

Add to Collection

Review Immunology

The hygiene hypothesis in autoimmunity: the role of pathogens and commensals

Jean-Francois Bach

NATURE REVIEWS IMMUNOLOGY (2018)

Add to Collection

Article Allergy

House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis

Y. Okamoto et al.

ALLERGY (2017)

Add to Collection

Review Immunology

Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells

Oscar Palomares et al.

IMMUNOLOGICAL REVIEWS (2017)

Add to Collection

Article Cell Biology

Human IgG2-and IgG4-expressing memory B cells display enhanced molecular and phenotypic signs of maturity and accumulate with age

Britt G. de Jong et al.

IMMUNOLOGY AND CELL BIOLOGY (2017)

Add to Collection

Article Allergy

Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers

Mohamed H. Shamji et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Add to Collection

Article Immunology

The immunology of the allergy epidemic and the hygiene hypothesis

Bart N. Lambrecht et al.

NATURE IMMUNOLOGY (2017)

Add to Collection

Article Allergy

Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper

M. H. Shamji et al.

ALLERGY (2017)

Add to Collection

Article Allergy

IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human

S. N. Freiberger et al.

ALLERGY (2016)

Add to Collection

Article Allergy

Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial

Petra Zieglmayer et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)

Add to Collection

Article Allergy

Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy

Claire Gueguen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Add to Collection

Article Allergy

Differential response in allergen-specific IgE, IgGs, and IgA levels for predicting outcome of oral immunotherapy

Mayumi Sugimoto et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2016)

Add to Collection

Article Allergy

Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score

Alain Didier et al.

CLINICAL AND TRANSLATIONAL ALLERGY (2015)

Add to Collection

Article Allergy

Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens

Muebeccel Akdis et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Add to Collection

Article Allergy

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

Karl-Christian Bergmann et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Add to Collection

Review Allergy

Sublingual immunotherapy: World Allergy Organization position paper 2013 update

Giorgio Walter Canonica et al.

WORLD ALLERGY ORGANIZATION JOURNAL (2014)

Add to Collection

Review Allergy

New Directions in Immunotherapy

Linda Cox et al.

CURRENT ALLERGY AND ASTHMA REPORTS (2013)

Add to Collection

Article Allergy

A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy

Aline Zimmer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Add to Collection

Article Allergy

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

Stephen R. Durham et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Add to Collection

Article Hematology

Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways

Magdalena A. Berkowska et al.

BLOOD (2011)

Add to Collection

Review Allergy

Long-term clinical and immunological effects of allergen immunotherapy

Aarif O. Eifan et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Add to Collection

Article Allergy

Structure and function of immunoglobulins

Harry W. Schroeder et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Add to Collection

Article Multidisciplinary Sciences

Vaccination with genetically engineered allergens prevents progression of allergic disease

V Niederberger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.